These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 11720831)

  • 21. Sodium citrate versus heparin catheter locks for cuffed central venous catheters: a single-center randomized controlled trial.
    Power A; Duncan N; Singh SK; Brown W; Dalby E; Edwards C; Lynch K; Prout V; Cairns T; Griffith M; McLean A; Palmer A; Taube D
    Am J Kidney Dis; 2009 Jun; 53(6):1034-41. PubMed ID: 19394731
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Percutaneous fibrin sheath stripping versus transcatheter urokinase infusion for malfunctioning well-positioned tunneled central venous dialysis catheters: a prospective, randomized trial.
    Gray RJ; Levitin A; Buck D; Brown LC; Sparling YH; Jablonski KA; Fessahaye A; Gupta AK
    J Vasc Interv Radiol; 2000 Oct; 11(9):1121-9. PubMed ID: 11041467
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Urokinase lock or flush solution for prevention of bloodstream infections associated with central venous catheters for chemotherapy: a meta-analysis of prospective randomized trials.
    Kethireddy S; Safdar N
    J Vasc Access; 2008; 9(1):51-7. PubMed ID: 18379981
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prophylaxis with urokinase in pediatric oncology patients with central venous catheters.
    Kalmanti M; Germanakis J; Stiakaki E; Syfridaki C; Christidou A; Tsetis D; Vardas P; Charisis G
    Pediatr Hematol Oncol; 2002; 19(3):173-9. PubMed ID: 11936730
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A prospective randomized double-blind trial of bolus urokinase in the treatment of established Hickman catheter sepsis in children.
    La Quaglia MP; Caldwell C; Lucas A; Corbally M; Heller G; Steinherz L; Brown AE; Groeger J; Exelby PR
    J Pediatr Surg; 1994 Jun; 29(6):742-5. PubMed ID: 8078010
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Morbidity using subcutaneous ports and efficacy of vancomycin flushing in cancer.
    Rubie H; Juricic M; Claeyssens S; Krimou A; Lemozy J; Izard P; Guitard J; Ane M; Prere MF; Fedacou F
    Arch Dis Child; 1995 Apr; 72(4):325-9. PubMed ID: 7763065
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Administering urokinase for catheter clearance.
    Mayo DJ
    Nursing; 1998 Dec; 28(12):50-2. PubMed ID: 9987281
    [No Abstract]   [Full Text] [Related]  

  • 28. A comparative double-blind, randomised trial of a new second generation LMWH (bemiparin) and UFH in the prevention of post-operative venous thromboembolism. The Bemiparin Assessment group.
    Kakkar VV; Howes J; Sharma V; Kadziola Z
    Thromb Haemost; 2000 Apr; 83(4):523-9. PubMed ID: 10780310
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ask the experts. Maintaining pulmonary artery catheter patency.
    Headley J
    Crit Care Nurse; 1998 Feb; 18(1):100-1. PubMed ID: 9515474
    [No Abstract]   [Full Text] [Related]  

  • 30. Taurolidine-based catheter lock regimen significantly reduces overall costs, infection, and dysfunction rates of tunneled hemodialysis catheters.
    Winnicki W; Herkner H; Lorenz M; Handisurya A; Kikić Ž; Bielesz B; Schairer B; Reiter T; Eskandary F; Sunder-Plassmann G; Sengoelge G
    Kidney Int; 2018 Mar; 93(3):753-760. PubMed ID: 28890326
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The matrix unloaded: aerosolized heparin or urokinase for pulmonary fibrosis.
    Idell S
    Am J Respir Crit Care Med; 2003 Dec; 168(11):1268-9. PubMed ID: 14644921
    [No Abstract]   [Full Text] [Related]  

  • 32. [Infectious and non-infectious complications of tunneled central catheters in hematologic patients].
    Albo López C; López Rodríguez D; Constenla Camba MI; Jimenéz Blanco A; Araujo LF; García-Medina J
    Sangre (Barc); 1999 Jun; 44(3):176-81. PubMed ID: 10481577
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Urokinase-containing locking solution in the prevention of dialysis catheter dysfunction: a double blind randomized controlled trial.
    Bonkain F; Van Hulle F; Janssens P; Catalano C; Allamani M; Stolear JC; Vandervelde D; Libertalis M; Treille S; Couttenye MM; Dhondt A; Van Biesen W; Fils JF; Tielemans C; Wissing KM
    J Vasc Access; 2017 Sep; 18(5):436-442. PubMed ID: 28623638
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A randomized, controlled trial of a new vascular catheter flush solution (minocycline-EDTA) in temporary hemodialysis access.
    Bleyer AJ; Mason L; Russell G; Raad II; Sherertz RJ
    Infect Control Hosp Epidemiol; 2005 Jun; 26(6):520-4. PubMed ID: 16018426
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Developing venous gangrene in deep vein thrombosis: intraarterial low-dose burst therapy with urokinase--case reports.
    Garg SK; Yadav KS
    Angiology; 1999 Feb; 50(2):157-62. PubMed ID: 10063948
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effectiveness of low dose urokinase on dialysis catheter thrombolysis.
    Seddon PA; Hrinya MK; Gaynord MA; Lion CM; Mangold BM; Bruns FJ
    ASAIO J; 1998; 44(5):M559-61. PubMed ID: 9804494
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic and acute consequences of a post-dialysis urokinase lock on permanent hemodialysis catheter function.
    Gabutti L; Mosconi E; Pellegrini L; Duchini F; Marone C
    J Nephrol; 2006; 19(2):183-8. PubMed ID: 16736417
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peripheral artery occlusion: treatment with abciximab plus urokinase versus with urokinase alone--a randomized pilot trial (the PROMPT Study). Platelet Receptor Antibodies in Order to Manage Peripheral Artery Thrombosis.
    Duda SH; Tepe G; Luz O; Ouriel K; Dietz K; Hahn U; Pereira P; Marsalek P; Ziemer G; Erley CM; Claussen CD
    Radiology; 2001 Dec; 221(3):689-96. PubMed ID: 11719664
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identifying complications of central venous catheters: infection, thrombosis, occlusion.
    Prescrire Int; 2009 Aug; 18(102):173-4. PubMed ID: 19746562
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Comparative study between 20 IU/ml heparin and 5% heparin/urokinase 5000 IU lock in hemodialysis central venous catheters with permeability problems].
    Pelayo Alonso R; Cobo Sánchez JL; de Buruaga Perea AS; Menezo Viadero R; Gándara Revuelta M; Aja Crespo A; Tovar Rincón A
    Rev Enferm; 2013 Mar; 36(3):8-12. PubMed ID: 23654184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.